High incidence of neutropenia in patients with prolonged ceftaroline exposure

Agranulocytosis with Ceftaroline High-Dose Monotherapy or Combination Therapy with Clindamycin

(2015) Neilmegh L. Varada et al.   PHARMACOTHERAPY

A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline

(2014) F. K. Yam et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations

(2014) Joseph A. Paladino et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline

(2014) Rupali Jain et al.   PHARMACOTHERAPY

Ceftaroline - a cause for neutropenia

(2013) R. H. Rimawi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy

(2012) T. T. Ho et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients

(2012) Jennifer C. Lin et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY